P-025 - AN OPEN-LABEL STUDY TO EVALUATE THE RELATIVE BIOAVAILABILITY OF SOTORASIB ADMINISTERED AS TABLETS OR AS A WATER DISPERSION IN HEALTHY SUBJECTS.
P. Cardona, M. Spring, J. Purkis, O. Mather, S. Dutta, B. Houk; Amgen Inc., Thousand Oaks, CA, USA.